What is the recommended dose for cellulitis treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Antibiotic Dosing for Cellulitis Treatment

For typical non-purulent cellulitis in adults, the standard dosing regimen is cephalexin 500 mg four times daily (every 6 hours) for 5 days, with extension if the infection has not improved within this time period. 1, 2

First-Line Treatment Options

Non-Purulent Cellulitis (Most Common)

  • Cephalexin 500 mg orally four times daily (every 6 hours) is the standard regimen for typical cellulitis caused by streptococci 1, 3
  • Alternative dosing: 500 mg every 12 hours may be used for skin and skin structure infections 3
  • Duration: 5 days is recommended, with extension if infection has not improved 2, 1
  • For severe infections, dosage may be doubled (up to 4g daily total) 3

Purulent Cellulitis (Associated with drainage/exudate)

  • Empirical coverage for CA-MRSA is recommended pending culture results 2
  • Options include:
    • Clindamycin 600 mg orally three times daily 2
    • Trimethoprim-sulfamethoxazole (TMP-SMX) 2
    • Tetracycline (doxycycline or minocycline) 2
    • Linezolid 600 mg twice daily 2

Treatment Considerations Based on Severity

Mild Cellulitis (Outpatient)

  • No systemic signs of infection, no altered mental status, hemodynamically stable 2
  • Oral antibiotics targeting streptococci (cephalexin) are appropriate 1
  • Recent evidence suggests high-dose cephalexin (1000 mg four times daily) may have fewer treatment failures than standard dose, though with more minor adverse effects 4

Moderate to Severe Cellulitis (Consider Hospitalization)

  • For hospitalized patients with complicated skin infections 2:
    • IV vancomycin 2
    • IV/oral linezolid 600 mg twice daily 2
    • IV daptomycin 4 mg/kg once daily 2
    • IV telavancin 10 mg/kg once daily 2
    • IV/oral clindamycin 600 mg three times daily 2

Special Situations Requiring MRSA Coverage

  • Cellulitis associated with:
    • Penetrating trauma 2, 1
    • Evidence of MRSA infection elsewhere 1, 5
    • Nasal colonization with MRSA 2
    • Injection drug use 2, 5
    • Systemic inflammatory response syndrome (SIRS) 2

Adjunctive Measures

  • Elevation of the affected area to reduce edema 2, 5
  • Treatment of predisposing factors (edema, obesity, eczema, venous insufficiency) 2
  • Examination of interdigital toe spaces in lower-extremity cellulitis 2, 1
  • For non-diabetic patients, systemic corticosteroids (prednisone 40 mg daily for 7 days) could be considered 2, 5

Common Pitfalls to Avoid

  • Don't extend treatment unnecessarily beyond 5 days if clinical improvement has occurred 1, 5
  • Don't automatically add MRSA coverage for typical non-purulent cellulitis without specific risk factors 1, 6
  • Don't overlook the importance of treating underlying conditions that may predispose to recurrent cellulitis 2, 1
  • Don't forget to consider high-dose cephalexin (1000 mg four times daily) in areas with high treatment failure rates 4

Prevention of Recurrence

  • For patients with 3-4 episodes per year, consider prophylactic antibiotics 2:
    • Oral penicillin or erythromycin twice daily for 4-52 weeks 2
    • Intramuscular benzathine penicillin every 2-4 weeks 2
  • Continue prophylaxis as long as predisposing factors persist 2

References

Guideline

Cephalexin Dosing and Management for Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Cellulitis in Older Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.